Safety And Efficacy Of The Bruton Tyrosine Kinase Inhibitor Zanubrutinib (Bgb-3111) In Patients With Waldenstrc6m Macroglobulinemia From A Phase 2 TrialGang An,Daobin Zhou,Weili Zhao,Keshu Zhou,Jianyong Li,Jianfeng Zhou,Liping Xie,Jie Jin,Liye Zhong,Lingzhi Yan,Haiyi Guo,Chenmu Du,Jane Huang,William Novotny,Jinhua Zhong,Lugui QiuBLOOD(2020)引用 2|浏览34暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要